Researchers at New York University are studying whether providing the opioid-addiction medicine extended-release naltrexone (Vivitrol) to individuals when they leave jail reduces their risk of relapse and overdose.
A new study aims to reduce hepatitis C (HCV) transmission among young adults who inject drugs. The study will equip participants with strategies to avoid situations and practices that put them at risk of contracting HCV.
There seem to be a growing number of cases of high amounts of fluid in the lungs following administration of the opioid overdose antidote naloxone, experts said at a recent meeting of the New York Society of Addiction Medicine annual meeting.
The practice of mindfulness may be helpful for people trying to reduce their dose of the opioid medication buprenorphine/naloxone (Suboxone), according to Zev Schuman-Olivier, MD, Executive Director, Center for Mindfulness and Compassion, Cambridge Health Alliance.
A growing body of research points to the relationship between alcohol and suicide. Taking steps to reduce the availability of alcohol may help to reduce the number of suicides, says Raul Caetano, M.D., Ph.D., Senior Research Scientist at the Prevention Research Center of the Pacific Institute for Research and Evaluation in Oakland, California.